Clinical Trial: Construction of a Predictive Model for Neoadjuvant Chemotherapy Response in Advanced High-Grade Serous Ovarian Cancer Based on Tumor-Infiltrating CD19⁺ B Cells: A National Multicenter Retrospective Validation Study (China)

Posted On: 2026-08-31

China, Aug. 31 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Construction of a Predictive Model for Neoadjuvant Chemotherapy Response in Advanced High-Grade Serous Ovarian Cancer Based on Tumor-Infiltrating CD19⁺ B Cells: A National Multicenter Retrospective Validation Study'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600131064

Registration Time: 2026/08/28

Type: Observational study

Primary Sponsor: Fudan University Shanghai Cancer Center

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=338364

Published by HT Digital Content Services with permission from Health Daily Digest....

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

Clinical Trial: Construction of a Predictive Model for Neoadjuvant Chemotherapy Response in Advanced High-Grade Serous Ovarian Cancer Based on Tumor-Infiltrating CD19⁺ B Cells: A National Multicenter Retrospective Validation Study (China)